Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ramosetron for Postoperative Bowel Motility in Gynecological Laparoscopic Surgery
NCT02849483Phase 4Unknown
- Sponsor
- Kyung Hee University Medical Center
- Start
- Jul 2016
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ramosetron in postoperative nausea and vomiting (PONV) and postoperative ileus (POI) (2 arms), sponsored by Kyung Hee University Medical Center. Primary endpoint: Time from surgery to the passage of first flatus. Status: unknown.
02
Drugs
ramosetron
03
Conditions
postoperative nausea and vomiting (PONV)postoperative ileus (POI)
Beyond the preview
Go deeper on NCT02849483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02849483.